EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Minimal clinically important difference in Alzheimer's disease: Rapid review

Ryan T Muir, Michael D Hill, Sandra E Black, Eric E Smith iD

Alzheimer's & Dementia · 2024-05 · 20 (5) · 3352-3363

DOI: 10.1002/alz.13770 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Alzheimer's & Dementia, 2024-04. Verfasst von Ryan T Muir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences and Department of Community Health Sciences, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Minimal Clinically Important Difference, Cognitive Dysfunction. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We conducted a rapid systematic review of minimal clinically important differences (MCIDs) for Alzheimer's disease (AD) trial endpoints. METHODS Two reviewers searched EMBASE, MEDLINE, and PubMed from inception to June 4, 2023. RESULTS Ten articles were retrieved. For mild cognitive impairment (MCI), a change of +2 to +3 points on the Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS‐Cog), +1 points on the Clinical Dementia Rating scale sum of boxes (CDR‐SB), −5 points on the integrated Alzheimer's Disease Rating Scale (iADRS), or −1 to −2 points on the Mini‐Mental State Examination (MMSE) was considered meaningful. For patients with mild AD, a change of +3 on the ADAS‐Cog, +2 points on CDR‐SB, −9 points on the iADRS, or −2 points on the MMSE was considered meaningful. For patients with moderate to severe AD, a change of +2 points on the CDR‐SB or a change of −1.4 to −3 points on the MMSE was considered meaningful. CONCLUSION This review identified previously published MCIDs for AD trial endpoints. Input from patients and caregivers will be needed to derive more meaningful endpoints and thresholds. Highlights This systematic rapid review identified thresholds for minimal clinically important differences (MCIDs) for recently used Alzheimer's disease (AD) trial endpoints: Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS‐Cog), Clinical Dementia Rating scale sum of boxes (CDR‐SB), integrated Alzheimer's Disease Rating Scale (iADRS), Mini‐Mental State Examination (MMSE). MCIDs were higher for more severe stages of AD. Average treatment effects in recent trials of anti‐amyloid disease modifying monoclonal antibodies are lower than previously published MCIDs. In future trials of disease modifying treatments for AD, the proportion of participants in each treatment group that experienced a clinically meaningful decline could be reported. More work is needed to incorporate the values and preferences of patients and care partners in deriving MCIDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMinimal Clinically Important DifferenceCognitive DysfunctionHumansMental Status and Dementia TestsNeuropsychological TestsClinical Trials as Topic

Stichwörter der Autor:innen

Alzheimer's diseaseclinical trialminimal clinically important difference

Autor:innen und Institutionen

  • Department of Clinical Neurosciences and Department of Community Health Sciences, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • L.C Campbell Cognitive Neurology Research Unit, Dr Sandra Black Centre for Brain Resilience and Recovery, and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

ORCID-Profile: Eric E Smith

Zitieren

APA

Muir, R. T., Hill, M. D., Black, S. E., & Smith, E. E. (2024). Minimal clinically important difference in Alzheimer's disease: Rapid review. Alzheimer's & Dementia, 20(5), 3352-3363. https://doi.org/10.1002/alz.13770

Vancouver

Muir RT, Hill MD, Black SE, Smith EE. Minimal clinically important difference in Alzheimer's disease: Rapid review. Alzheimer's & Dementia. 2024;20(5):3352-3363. doi:10.1002/alz.13770

BibTeX
@article{Muir2024,
  author = {Muir, Ryan T and Hill, Michael D and Black, Sandra E and Smith, Eric E},
  title = {Minimal clinically important difference in Alzheimer's disease: Rapid review},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {5},
  pages = {3352--3363},
  doi = {10.1002/alz.13770}
}
Kostenlos starten →